RebeccaMaeAllenMDMPH

Psychiatry • Seattle, WA

Neuropsychiatry

Partner, Director of Research & Neuropsychiatry, Seattle Neuropsychiatric Treatment Center

Join to view full profile

Dr. Allen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Allen's full profile

Already have an account?

Office
805 Madison St
Ste 401
Seattle, WA 98104
Phone+1 206-467-6300

Summary

Dr. Rebecca Allen is a psychiatrist in Seattle, WA. She received her medical degree from Oregon Health & Science University School of Medicine. She attended residency at Harvard Longwood and fellowship training at Brigham & Women's Hospital. She specializes in neuropsychiatry.

Education & Training

Beth Israel Deaconess Medical CenterChief Residency, Psychiatry, 2014 - 2015
Beth Israel Deaconess Medical CenterResidency, Psychiatry, 2011 - 2015
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 2011 - 2015
Oregon Health and Science University School of MedicineClass of 2011

Certifications & Licensure

WA State Medical License 2017 - 2026
ID State Medical License 2021 - 2025
MT State Medical License 2021 - 2025
MA State Medical License 2015 - 2018
American Board of Psychiatry and Neurology Psychiatry
UCNSBehavioral Neurology and Neuropsychiatry

Awards, Honors, & Recognition

Clinical TMS Society Service Award Clinical TMS Society, 2021

Clinical Trials

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression Start of enrollment: 2019 Sep 26
Recruiting
Not Applicable
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD Start of enrollment: 2023 Feb 14
Recruiting
Phase 3
Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD Start of enrollment: 2023 Aug 17
Recruiting
Phase 3

Publications & Presentations

PubMed

Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Walter Duffy, Mary Stedman
Brain Stimulation. 2024-04-02
Bilateral rTMS Shows No Advantage in Depression nor in Comorbid Depression and Anxiety: A Naturalistic Study.
Rebecca M Allen, James M Scanlan, Larissa Gama-Chonlon
The Psychiatric Quarterly. 2024-03-01
4 citations
Could bipolar depressed patients respond better to rTMS than unipolar depressed patients? A naturalistic, observational study.
Larissa Gama-Chonlon, James M Scanlan, Rebecca M Allen
Psychiatry Research. 2022-06-01